Artemis Investment Management LLP Sells 7,303 Shares of Unum Group (NYSE:UNM)

Artemis Investment Management LLP reduced its holdings in Unum Group (NYSE:UNM - Free Report) by 3.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 225,448 shares of the financial services provider's stock after selling 7,303 shares during the quarter. Artemis Investment Management LLP owned 0.12% of Unum Group worth $16,464,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Capital Performance Advisors LLP bought a new position in shares of Unum Group in the third quarter valued at approximately $31,000. Thurston Springer Miller Herd & Titak Inc. bought a new position in Unum Group during the 3rd quarter valued at $37,000. V Square Quantitative Management LLC increased its position in shares of Unum Group by 38.2% during the 3rd quarter. V Square Quantitative Management LLC now owns 702 shares of the financial services provider's stock valued at $42,000 after purchasing an additional 194 shares during the period. William B. Walkup & Associates Inc. bought a new stake in shares of Unum Group in the 2nd quarter worth $44,000. Finally, Quarry LP lifted its holdings in shares of Unum Group by 4,794.7% in the third quarter. Quarry LP now owns 930 shares of the financial services provider's stock valued at $55,000 after buying an additional 911 shares during the period. Institutional investors own 86.57% of the company's stock.

Insider Activity at Unum Group

In other news, EVP Elizabeth Claire Ahmed sold 5,000 shares of the stock in a transaction dated Thursday, October 31st. The stock was sold at an average price of $64.16, for a total transaction of $320,800.00. Following the transaction, the executive vice president now owns 58,741 shares of the company's stock, valued at approximately $3,768,822.56. This represents a 7.84 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Christopher W. Pyne sold 3,250 shares of the business's stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $70.02, for a total value of $227,565.00. Following the completion of the sale, the executive vice president now owns 50,762 shares of the company's stock, valued at approximately $3,554,355.24. This trade represents a 6.02 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 107,914 shares of company stock valued at $7,998,745. 0.93% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of research firms recently issued reports on UNM. Morgan Stanley lifted their target price on Unum Group from $62.00 to $64.00 and gave the stock an "equal weight" rating in a report on Wednesday, October 30th. Evercore ISI upgraded shares of Unum Group from an "in-line" rating to an "outperform" rating and boosted their target price for the stock from $67.00 to $84.00 in a report on Thursday, November 14th. Truist Financial raised their target price on shares of Unum Group from $70.00 to $75.00 and gave the stock a "buy" rating in a report on Friday, November 1st. Wells Fargo & Company upped their price target on Unum Group from $74.00 to $81.00 and gave the company an "overweight" rating in a report on Tuesday, January 14th. Finally, JPMorgan Chase & Co. restated a "neutral" rating and issued a $79.00 target price (up from $74.00) on shares of Unum Group in a report on Tuesday, January 7th. Five research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $75.45.

Unum Group Stock Up 1.0 %

Shares of UNM stock traded up $0.72 during trading on Monday, hitting $75.02. 911,396 shares of the company were exchanged, compared to its average volume of 1,149,464. The firm has a market capitalization of $13.70 billion, a price-to-earnings ratio of 8.12, a P/E/G ratio of 0.97 and a beta of 0.81. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.28 and a current ratio of 0.28. The business's 50-day simple moving average is $73.60 and its 200 day simple moving average is $62.97. Unum Group has a twelve month low of $45.23 and a twelve month high of $77.63.

Unum Group (NYSE:UNM - Get Free Report) last posted its quarterly earnings results on Tuesday, October 29th. The financial services provider reported $2.13 EPS for the quarter, beating the consensus estimate of $2.10 by $0.03. Unum Group had a net margin of 13.76% and a return on equity of 15.21%. The business had revenue of $3.22 billion for the quarter, compared to analysts' expectations of $3.26 billion. During the same period in the previous year, the company posted $1.94 EPS. Unum Group's revenue was up 4.0% on a year-over-year basis. As a group, analysts forecast that Unum Group will post 8.54 EPS for the current fiscal year.

Unum Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Friday, January 24th will be issued a dividend of $0.42 per share. The ex-dividend date is Friday, January 24th. This represents a $1.68 annualized dividend and a dividend yield of 2.24%. Unum Group's dividend payout ratio is 18.18%.

Unum Group Company Profile

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.